The program has since grown to a network of 27 partner teams with one team at each Sanofi site in
France, with 150 members who share feedback and best practice. More than 350 employees have benefited (42% sick employees, 30% caregivers, 28% managers).
The global program announced today echoes the original approach and makes Sanofi an ever more inclusive culture where everyday experiences matter for
every employee worldwide. This wraps the program into a wider DE&I cultural transformation at Sanofi as the company drives Diversity, Equity, and Inclusion (DE&I) in and beyond the workplace.
Global impact of cancer and work
Of all chronic conditions, cancer had the highest prevalence of work loss. Research shows that the risk of losing a persons job in the EU
increases 1.4 times after a cancer diagnosis1. According to an article published in the Journal of the National Cancer Institute, cancer-related employment changes are experienced by more than 40%
of cancer survivors who were employed at or after diagnosis in the US2.
Worldwide, the number
of people diagnosed with cancer who are of working age is significant. For example, around 45% of people diagnosed in the U.S. in 2020 were between 2064 years old3. In France, around
160, 000 of the 400,000 people newly diagnosed with cancer were of working age and in the UK, around 900,000 people of working age are living with cancer. In a recent Harris poll conducted last year in the U.S. by Cancer & Careers, 35%
said that in general, those with cancer face stigma in the workplace. Yet, that same study revealed 78% felt that people who have been diagnosed with cancer and receive support from their employer are more likely to thrive in the workplace.
About Sanofi DE&I strategy
Sanofis ambitious DE&I strategy was launched in June 2021 with set objectives toward 2025, built around three key pillars: building
representative leadership, creating a work environment where employees can bring the best of their whole selves and engaging with the companys diverse communities.
Read more information on Sanofis DE&I strategy here.
About Sanofi
We are
an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve peoples lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the
impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media Relations
Sandrine
Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.com
Victor Rouault | + 33 6 70 93 71 40 | victor.rouault@sanofi.com
Evan Berland | +1 215 432 0234 |
evan.berland@sanofi.com
Timothy Gilbert |
+ 1 516 521 2929 | timothy.gilbert@sanofi.com
Nicolas Obrist | + 33 6 77 21 27 55 | nicolas.obrist@sanofi.com
Sally Bain | + 1 617 834 6026 |
sally.bain@sanofi.com
* Specific criteria identifying the conditions and circumstances that are eligible for coverage under this program might be governed by the terms and conditions of country-specific policies or legal
requirements.
1 Cancer survivors and unemployment: a meta-analysis and meta-regression -
PubMed (nih.gov)
2 Employment Outcomes Among Cancer Survivors in the United States:
Implications for Cancer Care Delivery | JNCI: Journal of the National Cancer Institute | Oxford Academic (oup.com)
3 Binder, V. Gany, F., (2020) Impact of Cancer on Employment. Journal of Clinical Oncology, 2020 Feb 1; 38(4): 302-309.
|
|
|
|
|
2/3 |